20 June 2013
Keywords: benefits, pfizer, voriconazole, shown, vfend, been, effective
Article | 12 August 2002
Pfizer's Vfend (voriconazole) has been shown to be more effective intreating lethal fungal infections in transplant and cancer patients and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 August 2002
5 August 2002
19 June 2013
© 2013 thepharmaletter.com